Cogentin and Escitalopram drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Cogentin (benztropine mesylate) and Escitalopram (escitalopram oxalate). Common drug interactions include rhabdomyolysis among females and speech disorder among males.
The phase IV clinical study analyzes what interactions people have when they take Cogentin and Escitalopram. It is created by eHealthMe based on reports of 37 people who take the same drugs from the FDA, and is updated regularly.
What is Cogentin?
Cogentin has active ingredients of benztropine mesylate. It is often used in tardive dyskinesia. eHealthMe is studying from 7,692 Cogentin users. Check the latest studies of Cogentin.
What is Escitalopram?
Escitalopram has active ingredients of escitalopram oxalate. It is often used in depression. eHealthMe is studying from 78,081 Escitalopram users. Check the latest studies of Escitalopram.
37 people who take Cogentin and Escitalopram together, and have interactions are studied.

What are the common drug interactions of Cogentin and Escitalopram, by gender? *:
female:
- Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
- Accommodation disorder
- Diplopia (double vision)
- Hypoaesthesia (reduced sense of touch or sensation)
- Psychotic disorder
- Strabismus (a disorder in which the two eyes do not line up in the same direction)
- Visual acuity reduced (reduced clearness of vision)
- Affect lability (emotional incontinence)
- Alopecia (absence of hair from areas of the body)
- Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
male:
- Speech disorder
- Dysphagia (a condition in which swallowing is difficult or painful)
- Diarrhoea
- Drooling (drop saliva uncontrollably from the mouth)
- Dysstasia (difficulty in standing)
- Emotional distress
- Eye swelling
- Fatigue (feeling of tiredness)
- Hallucination (an experience involving the perception of something not present)
- Hypertension (high blood pressure)
What are the common drug interactions of Cogentin and Escitalopram, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
- Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
20-29:
- Accommodation disorder
- Diplopia (double vision)
- Strabismus (a disorder in which the two eyes do not line up in the same direction)
- Visual acuity reduced (reduced clearness of vision)
- Overdose
- Pupillary reflex impaired
- Weight increased
30-39:
- Arrhythmia (irregular heartbeat)
- Palpitations (feelings or sensations that your heart is pounding or racing)
- Tachycardia (a heart rate that exceeds the range of 100 beats/min)
40-49:
- Blood triglycerides increased
- Death
- Hypertension (high blood pressure)
- Type 2 diabetes mellitus
- Abdominal pain
- Aggression
- Agitation (state of anxiety or nervous excitement)
- Arthralgia (joint pain)
- Asthenia (weakness)
- Back pain
50-59:
- Physical disability
- Pneumonia
- Psychiatric symptom
- Restless legs syndrome (a powerful urge to move your legs)
- Road traffic accident
- Salivary hypersecretion (excess saliva secretion)
- Scab (a hard coating on the skin formed during the wound healing)
- Scratch
- Skin haemorrhage (bleeding into skin)
- Somnolence (a state of near-sleep, a strong desire for sleep)
60+:
- Gait disturbance
- Speech disorder
- Depressed level of consciousness
- Drooling (drop saliva uncontrollably from the mouth)
- Dysphonia (speech disorder attributable to a disorder of phonation)
- Eye swelling
- Hallucination (an experience involving the perception of something not present)
- Hypersomnia (excessive daytime sleepiness (eds))
- Oedema peripheral (superficial swelling)
- Psychotic disorder
What are the existing conditions these people have? *
- Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 14 people, 37.84%
- Psychotic Disorder: 12 people, 32.43%
- Encephalitis Autoimmune (autoimmune origin disturbances of consciousness and pyramidal signs, inflammation of the brain): 6 people, 16.22%
- Parkinson's Disease: 4 people, 10.81%
- Hallucinations (sensations that appear real but are created by your mind): 4 people, 10.81%
- Paranoia (psychotic disorder characterized by delusions of persecution with or without grandeur): 3 people, 8.11%
- Stress And Anxiety: 2 people, 5.41%
- Schizoaffective Disorder (a mental disorder characterized by disordered thought): 2 people, 5.41%
- Major Depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings): 2 people, 5.41%
- Hypersensitivity: 2 people, 5.41%
* Approximation only. Some reports may have incomplete information.
Do you take Cogentin and Escitalopram?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Cogentin (7,692 reports)
- Escitalopram (78,081 reports)
Browse all drug interactions of Cogentin and Escitalopram:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Cogentin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Escitalopram:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Cogentin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Escitalopram and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- O’Brien FE, O’Connor RM, Clarke G, Donovan MD, Dinan TG, Griffin BT, Cryan JF, "The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram", Behavioural brain research, 2014 Mar .
- O’Brien FE, O’Connor RM, Clarke G, Donovan MD, Dinan TG, Griffin BT, Cryan JF, "The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram", Behavioural brain research, 2014 Mar .
How the study uses the data?
The study uses data from the FDA. It is based on benztropine mesylate and escitalopram oxalate (the active ingredients of Cogentin and Escitalopram, respectively), and Cogentin and Escitalopram (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Fibromyalgia and drugs of ingredients of hydrocodone bitartrate; ibuprofen - now
- Folic Acid and Dizziness for Women aged 50-59 - 3 seconds ago
- Folic Acid and Lightheadedness for Women aged 50-59 - 3 seconds ago
- Folic Acid and Vertigo for Women aged 50-59 - 3 seconds ago
- Folic Acid and Loss Of Balance for Women aged 50-59 - 4 seconds ago
- Folic Acid and Lightheadedness - Dizzy for Women aged 50-59 - 4 seconds ago
- Folic Acid and Light-Headedness When Standing Up for Women aged 50-59 - 4 seconds ago
- Placental Disorder and drugs of ingredients of valproic acid - 5 seconds ago
- Drug interactions of Palbociclib and Insulin - 6 seconds ago
- Ondansetron and Efavirenz drug interactions for men aged 20-29 - 13 seconds ago